Filing Flows › Rapid Micro Biosystems (RPID) › Q2 2026 › vs Q2 2025
Rapid Micro Biosystems (RPID) Q2 2026 vs Q2 2025 (year over year)
Rapid Micro Biosystems's revenue rose $792K (+11%) from $7.3M in Q2 2025 to $8.1M in Q2 2026. The biggest changes: Product +$484K (+10%); Service +$308K (+13%).
Rapid Micro Biosystems, Q2 2026: revenue $8.1M (+11% year over year), operating margin -153.0%, net loss $12.9M, operating cash flow −$12.7M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Product | $5.3M | $4.8M | $484K | +10% |
| Service | $2.8M | $2.5M | $308K | +13% |
| Revenue | $8.1M | $7.3M | $792K | +11% |
| Net loss | $12.9M | $11.9M | $1.1M | +9% |
| Costs & expenses | $21.0M | $19.4M | $1.6M | +8% |
| Operating costs | $20.4M | $19.4M | $966K | +5% |
| Interest & other, net | $556K | −$301K | $857K | — |
| Income tax | $45K | $11K | $34K | +309% |
| Cost of revenue | $6.8M | $7.0M | −$145K | -2% |
| Research & development | $3.3M | $3.2M | $102K | +3% |
| Sales & marketing | $3.4M | $3.1M | $322K | +10% |
| General & admin | $6.8M | $6.1M | $687K | +11% |
| Operating cash sources | $14.7M | $11.7M | $3.0M | +25% |
| Depreciation & amortization | $674K | $811K | −$137K | -17% |
| Share-based compensation | $1.3M | $1.2M | $103K | +8% |
| Cash used in operations | $12.7M | $9.7M | $3.0M | +31% |
| Net loss absorbed | $12.9M | $11.9M | $1.1M | +9% |
| Working capital & other | $1.8M | −$129K | $1.9M | — |
Questions
How much did Rapid Micro Biosystems's revenue grow year over year in Q2 2026?
Rapid Micro Biosystems's revenue rose $792K (+11%) from $7.3M in Q2 2025 to $8.1M in Q2 2026.
What drove Rapid Micro Biosystems's revenue change in Q2 2026?
Product +$484K (+10%); Service +$308K (+13%).